Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
miR-7 expression in serous ovarian carcinomas.
Swiercz A, Chechlinska M, Kupryjanczyk J, Dansonka-Mieszkowska A, Rembiszewska A, Goryca K, Kulinczak M, Zajdel M, Sromek M, Siwicki JK. Swiercz A, et al. Among authors: kupryjanczyk j. Anticancer Res. 2015 Apr;35(4):2423-9. Anticancer Res. 2015. PMID: 25862909
Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen.
Kupryjańczyk J, Szymańska T, Madry R, Timorek A, Stelmachów J, Karpińska G, Rembiszewska A, Ziółkowska I, Kraszewska E, Debniak J, Emerich J, Ułańska M, Płuzańska A, Jedryka M, Goluda M, Chudecka-Głaz A, Rzepka-Górska I, Klimek M, Urbański K, Breborowicz J, Zieliński J, Markowska J. Kupryjańczyk J, et al. Br J Cancer. 2003 Mar 24;88(6):848-54. doi: 10.1038/sj.bjc.6600789. Br J Cancer. 2003. PMID: 12644821 Free PMC article.
P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.
Plisiecka-Hałasa J, Karpińska G, Szymańska T, Ziółkowska I, Madry R, Timorek A, Debniak J, Ułańska M, Jedryka M, Chudecka-Głaz A, Klimek M, Rembiszewska A, Kraszewska E, Dybowski B, Markowska J, Emerich J, Płuzańska A, Goluda M, Rzepka-Górska I, Urbański K, Zieliński J, Stelmachów J, Chrabowska M, Kupryjańczyk J. Plisiecka-Hałasa J, et al. Among authors: kupryjanczyk j. Ann Oncol. 2003 Jul;14(7):1078-85. doi: 10.1093/annonc/mdg299. Ann Oncol. 2003. PMID: 12853350 Free article.
TP53 status determines clinical significance of ERBB2 expression in ovarian cancer.
Kupryjańczyk J, Madry R, Plisiecka-Hałasa J, Bar J, Kraszewska E, Ziółkowska I, Timorek A, Stelmachów J, Emerich J, Jedryka M, Płuzańska A, Rzepka-Górska I, Urbański K, Zieliński J, Markowska J. Kupryjańczyk J, et al. Br J Cancer. 2004 Nov 29;91(11):1916-23. doi: 10.1038/sj.bjc.6602238. Br J Cancer. 2004. PMID: 15545967 Free PMC article.
124 results